Skip to main content

Home
Specialties
Resources
CME

Search Videos and More

search

Channel Categories

Breast Cancer (2)
Cancer Screening and Survivorship (2)
Cell Therapy (32)
Clinical Trials (2)
Gastrointestinal Cancer (2)
Genitourinary Cancer (2)
Gynecologic Oncology (2)
Head and Neck Cancer (2)
Hematologic Oncology (13)
Immunotherapy (15)
Neuro-Oncology (2)
Pediatric Hematology/Oncology (2)
Primary Care (2)
Radiation Oncology (2)
Skin Cancer (3)
Thoracic Cancer (2)
Young Adult Malignancies (2)

Types

News (20)
Symposium (1)
Video Asset (11)

Showing 1 - 12 of 32 results

Previous| 1 | 2 | 3 |Next

Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo

Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo

Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients

Graft Versus Host Disease No Longer Poses High Risk to Transplant Patients

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

Next Generation Armored Car T-Cell Therapy Trial Now Open

Next Generation Armored Car T-Cell Therapy Trial Now Open

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

First-in-Human Clinical Trial for B-cell Lymphoma Using “Armored” CAR T Cells Opens at Roswell Park

First-in-Human Clinical Trial for B-cell Lymphoma Using “Armored” CAR T Cells Opens at Roswell Park

A Comprehensive Overview of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma

A Comprehensive Overview of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma

For Roswell Park’s Cell Therapy Team, Innovation is the Norm

For Roswell Park’s Cell Therapy Team, Innovation is the Norm

Meet the Team: Shernan Holtan, MD

Meet the Team: Shernan Holtan, MD

Amtagvi, First FDA-Approved Cell Therapy for Solid-Tumor Cancers, Available at Roswell Park

Amtagvi, First FDA-Approved Cell Therapy for Solid-Tumor Cancers, Available at Roswell Park

Meet the Innovation Hub Team

Meet the Innovation Hub Team

Showing 1 - 12 of 32 results

Previous| 1 | 2 | 3 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer